Eric Dane's death has drawn attention to how quickly ALS can progress in rare cases. While the disease is typically ...

ALS is a progressive disease and it can take about 2-5 years from the time of diagnosis to death. Some people might live for ...

Eric Dane's death after battling ALS brings attention to the progressive illness affecting 5,000 Americans yearly with only a ...

This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...

- AMX0114 is an Amylyx-developed antisense oligonucleotide designed to target calpain-2, a key contributor to the axonal degeneration pathway in ALS “Obtaining FDA Fast Track designation for AMX0114 ...

Before actor Eric Dane died after a two-year battle with ALS in Feb. 2026, he shared details about life with ALS and how the ...

AMX0114 is an investigational antisense oligonucleotide targeting calpain-2, a calcium-activated protease believed to play a role in ALS disease progression. The Food and Drug Administration (FDA) has ...

Please provide your email address to receive an email when new articles are posted on . AMX0114 was developed to target calpain-2, a driver of axonal neurodegeneration. A pending clinical trial will ...

- AMX0114 is an Amylyx-developed antisense oligonucleotide designed to target calpain-2, a key contributor to the axonal degeneration pathway in ALS - Phase 1 LUMINA trial of AMX0114 underway; early ...

Eric Dane advocated for a cure for Amyotrophic Lateral Sclerosis (ALS) as the progression of his symptoms was on full display in a campaign video. After the “Euphoria” actor missed the planned “Grey’s ...